XML 52 R40.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation Plans (Tables)
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Summary Of Stock Option Activity
A summary of the Company's stock option activity for the three months ended March 31, 2021 and March 31, 2020 is presented below:
Stock OptionsCommon
Shares
Weighted
Average
Strike Price
Remaining
Contractual
Term (1)
Intrinsic
Value (2)
(in thousands)
Outstanding at January 1, 2021520,663 $42.47 
Granted  
Exercised(208,579)42.96 
Forfeited or canceled(590)46.86 
Outstanding at March 31, 2021
311,494 $42.14 1.8$10,485 
Exercisable at March 31, 2021
309,945 $42.11 1.8$10,441 
Stock OptionsCommon
Shares
Weighted
Average
Strike Price
Remaining
Contractual
Term (1)
Intrinsic
Value (2)
(in thousands)
Outstanding at January 1, 2020755,332 $42.43 
Granted— — 
Exercised(94,653)38.69 
Forfeited or canceled— — 
Outstanding at March 31, 2020
660,679 $42.97 2.5$— 
Exercisable at March 31, 2020
650,456 $42.95 2.4$
(1)Represents the remaining weighted average contractual life in years.
(2)Aggregate intrinsic value represents the total pre-tax intrinsic value (i.e., the difference between the Company's stock price on the last trading day of the quarter and the option exercise price, multiplied by the number of shares) that would have been received by the option holders if they had exercised their options on the last day of the quarter. Options with exercise prices above the stock price on the last trading day of the quarter are excluded from the calculation of intrinsic value. The intrinsic value will change based on the fair market value of the Company's stock.
Summary Of Plans' Restricted Share And Performance-Vested Stock Award Activity
A summary of the Plans' restricted share activity for the three months ended March 31, 2021 and March 31, 2020 is presented below:
Three months ended March 31, 2021Three months ended March 31, 2020
Restricted SharesCommon
Shares
Weighted
Average
Grant-Date
Fair Value
Common
Shares
Weighted
Average
Grant-Date
Fair Value
Outstanding at January 1234,794 $59.02 144,328 $60.37 
Granted257,189 62.79 99,963 64.10 
Vested and issued(7,104)78.13 (9,633)75.69 
Forfeited or canceled(849)63.44 (3,538)81.89 
Outstanding at March 31484,030 $60.73 231,120 $61.02 
Vested, but not issuable at March 3194,348 $52.21 92,244 $52.23 

A summary of the Plans' performance-based stock award activity, based on the target level of the awards, for the three months ended March 31, 2021 and March 31, 2020 is presented below:
Three months ended March 31, 2021Three months ended March 31, 2020
Performance-based Stock Common
Shares
Weighted
Average
Grant-Date
Fair Value
Common
Shares
Weighted
Average
Grant-Date
Fair Value
Outstanding at January 1482,608 $71.15 465,515 $74.37 
Granted206,465 58.85 166,547 64.10 
Added by performance factor at vesting  48,831 72.59 
Vested and issued  (180,596)72.59 
Expired, canceled or forfeited(125,622)87.88 (6,071)73.66 
Outstanding at March 31563,451 $62.91 494,226 $71.39 
Vested, but deferred at March 3134,748 $43.28 34,166 $43.27